Transarterial radioembolization versus concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma: A propensity score matching analysis

Both transarterial radioembolization (TARE) and concurrent chemoradiation therapy (CCRT) result in comparably good treatment outcomes in locally advanced hepatocellular carcinoma (HCC), but it is unclear if they are of similar efficacy or have similar safety profiles. We compared the effectiveness of these modalities in patients with locally advanced HCC. Treatment outcomes for TARE and CCRT were comparable, but the role of two modalities as bridge to curative therapy requires further investigations.

http://ift.tt/2rEikSP